Skip to main content

Carbidopa / Levodopa News

Monthly News Roundup - August 2024

FDA Clears Pfizer and Moderna 2024-2025 COVID-19 mRNA Vaccines  On August 22, the FDA approved the latest COVID-19 mRNA monovalent vaccines from Moderna (Spikevax) and Pfizer / BioNTech (Comirnaty) ...

FDA Approves Crexont (carbidopa and levodopa) Extended-Release Capsules for the Treatment of Parkinson’s Disease

BRIDGEWATER, N.J.--(BUSINESS WIRE) August 7, 2024 – Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) (“Amneal” or the “Company”) today announced that the U.S. Food and Drug Administration (FDA) has appro...

FDA Approves Duopa (carbidopa and levodopa) Enteral Suspension for Parkinson's Disease

NORTH CHICAGO, Ill., Jan. 12, 2015 /PRNewswire/ – The U.S. Food and Drug Administration (FDA) has approved AbbVie's (NYSE: ABBV) Duopa (carbidopa and levodopa) enteral suspension for the treatment...

Impax Pharmaceuticals Announce FDA Approval of Rytary (carbidopa and levodopa) for Parkinson's Disease

HAYWARD, Calif., Jan. 8, 2015 /PRNewswire/ – Impax Pharmaceuticals, a division of Impax Laboratories, Inc. (NASDAQ: IPXL), today announced that the U.S. Food and Drug Administration (FDA) approved...

Ask a question

To post your own question to our community, sign in or create an account.

Further information

Related condition support groups

Parkinson's Disease, Restless Legs Syndrome

Carbidopa / Levodopa patient information at Drugs.com